Multidimensional analyses reveal distinct immune microenvironment in hepatitis B virus-related hepatocellular carcinoma. Issue 5 (3rd July 2018)
- Record Type:
- Journal Article
- Title:
- Multidimensional analyses reveal distinct immune microenvironment in hepatitis B virus-related hepatocellular carcinoma. Issue 5 (3rd July 2018)
- Main Title:
- Multidimensional analyses reveal distinct immune microenvironment in hepatitis B virus-related hepatocellular carcinoma
- Authors:
- Lim, Chun Jye
Lee, Yun Hua
Pan, Lu
Lai, Liyun
Chua, Camillus
Wasser, Martin
Lim, Tony Kiat Hon
Yeong, Joe
Toh, Han Chong
Lee, Ser Yee
Chan, Chung Yip
Goh, Brian KP
Chung, Alexander
Heikenwälder, Mathias
Ng, Irene OL
Chow, Pierce
Albani, Salvatore
Chew, Valerie - Abstract:
- Abstract : Background and aims: Chronic inflammation induced by chronic hepatitis B virus (HBV) infection increases the risk of hepatocellular carcinoma (HCC). However, little is known about the immune landscape of HBV-related HCC and its influence on the design of effective cancer immunotherapeutics. Methods: We interrogated the immune microenvironments of HBV-related HCC and non-viral-related HCC using immunohistochemistry and cytometry by time-of-flight (CyTOF). On identifying unique immune subsets enriched in HBV-related HCC, we further interrogated their phenotypes and functions using next-generation sequencing (NGS) and in vitro T-cell proliferation assays. Results: In-depth interrogation of the immune landscapes showed that regulatory T cells (TREG ) and CD8 + resident memory T cells (TRM ) were enriched in HBV-related HCC, whereas Tim-3 + CD8 + T cells and CD244 + natural killer cells were enriched in non-viral-related HCC. NGS of isolated TREG and TRM from HBV-related HCC and non-viral-related HCC identified distinct functional signatures associated with T-cell receptor signalling, T-cell costimulation, antigen presentation and programmed cell death protein 1 (PD-1) signalling. TREG and TRM from HBV-related HCC expressed more PD-1 and were functionally more suppressive and exhausted than those from non-virus-related HCC. Furthermore, immunosuppression by PD-1 + TREG could be reversed with anti-PD-1 blockade. Using multiplexed tissue immunofluorescence, we furtherAbstract : Background and aims: Chronic inflammation induced by chronic hepatitis B virus (HBV) infection increases the risk of hepatocellular carcinoma (HCC). However, little is known about the immune landscape of HBV-related HCC and its influence on the design of effective cancer immunotherapeutics. Methods: We interrogated the immune microenvironments of HBV-related HCC and non-viral-related HCC using immunohistochemistry and cytometry by time-of-flight (CyTOF). On identifying unique immune subsets enriched in HBV-related HCC, we further interrogated their phenotypes and functions using next-generation sequencing (NGS) and in vitro T-cell proliferation assays. Results: In-depth interrogation of the immune landscapes showed that regulatory T cells (TREG ) and CD8 + resident memory T cells (TRM ) were enriched in HBV-related HCC, whereas Tim-3 + CD8 + T cells and CD244 + natural killer cells were enriched in non-viral-related HCC. NGS of isolated TREG and TRM from HBV-related HCC and non-viral-related HCC identified distinct functional signatures associated with T-cell receptor signalling, T-cell costimulation, antigen presentation and programmed cell death protein 1 (PD-1) signalling. TREG and TRM from HBV-related HCC expressed more PD-1 and were functionally more suppressive and exhausted than those from non-virus-related HCC. Furthermore, immunosuppression by PD-1 + TREG could be reversed with anti-PD-1 blockade. Using multiplexed tissue immunofluorescence, we further demonstrated that TREG and TRM contributed to overall patient survival: TREG were associated with a poor prognosis and TRM were associated with a good prognosis in HCC. Conclusion: We have shown that the HBV-related HCC microenvironment is more immunosuppressive and exhausted than the non-viral-related HCC microenvironment. Such in-depth understanding has important implications in disease management and appropriate application of immunotherapeutics. … (more)
- Is Part Of:
- Gut. Volume 68:Issue 5(2019)
- Journal:
- Gut
- Issue:
- Volume 68:Issue 5(2019)
- Issue Display:
- Volume 68, Issue 5 (2019)
- Year:
- 2019
- Volume:
- 68
- Issue:
- 5
- Issue Sort Value:
- 2019-0068-0005-0000
- Page Start:
- 916
- Page End:
- 927
- Publication Date:
- 2018-07-03
- Subjects:
- hepatitis B -- hepatocellular carcinoma -- immunotherapy -- cancer immunobiology -- immunoregulation
Gastroenterology -- Periodicals
616.33 - Journal URLs:
- http://gut.bmjjournals.com ↗
http://www.bmj.com/archive ↗ - DOI:
- 10.1136/gutjnl-2018-316510 ↗
- Languages:
- English
- ISSNs:
- 0017-5749
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 19747.xml